Abstract. Acute mesenteric ischemia is a condition with a high mortality rate. In the present study, a novel hybrid technique for the treatment of acute mesenteric ischemia was investigated. The retrospective study population included six patients, of which five were male and one was female, with a mean age of 69 years (age range, 59-73 years). The hybrid technique involved isolating the superior mesenteric artery (SMA) for cannulation and subsequently performing a fluoroscopically-assisted embolectomy, retrograde balloon angioplasty and stenting. Intra-arterial, catheter-directed thrombolysis was performed if required. Bowels showing evident necrosis were resected, while ischemic bowels with the potential for recovery were left for 48 h before being re-examined during the second-look surgery. Retrograde open mesenteric stenting (ROMS) was successfully performed on two patients without bowel resection. Four patients were successfully treated by intra-arterial catheter-directed thrombolysis following recanalization of the SMA, and the ischemic bowels had exhibited a full recovery by the second-look operation. Three patients underwent a massive bowel resection, but did not develop short bowel syndrome. Two patients developed acute renal failure, one of which recovered after 10 days of dialysis, while the other patient succumbed to acute renal failure. In the five surviving patients, the SMA remained patent for the duration of the follow-up period. Therefore, ROMS was shown to be a viable alternative procedure for emergent SMA revascularization. In addition, intra-arterial catheter-directed thrombolysis following recanalization of the SMA was demonstrated as an alternative technique for inhibiting necrosis in bowels with acute mesenteric ischemia.
Introduction
Acute mesenteric ischemia is a life-threatening condition with a mortality rate of 40% (1) . The condition is commonly caused by acute thrombosis of a partially occluded atherosclerotic lesion. The perioperative mortality rate of thrombosis in the superior mesenteric artery (SMA) is relatively high due to the difficulty of diagnosis, the extent of bowel ischemia infarction and the complexity of surgical revascularization (2) . Treatments for superior mesenteric artery thrombosis include non-surgical treatment (anticoagulant medicines) and surgical treatment, including endarterectomy, artery bypass, artery segmental resection and anastomosis, and intraarterial catheter-directed thrombolysis. During surgery, bowels with necrosis require resection and follow-up surgery is necessary to protect the remaining ischemic bowel tissues (3) . Hybrid surgical techniques, a type of surgical treatment combining the advantages of open surgical and endovascular approaches, are widely used and include retrograde open mesenteric stenting (ROMS), which is effective in treating thrombosis in SMA (4) . The present study investigated a hybrid approach for treating patients suffering from acute SMA thrombosis, which employed fluoroscopically-assisted embolectomy and balloon angioplasty, combined with catheter-directed thrombolysis during the laparotomy (5).
Materials and methods
Patients. The hybrid technique was conducted on six patients with acute SMA thrombosis, of which five were male and one was female. Comorbid medical conditions, radiological findings, perioperative data and follow-up information were obtained for all patients (Table I) . Three patients presented with sudden and severe abdominal pain, out of proportion with the physical findings, while the other three patients exhibited diffuse, severe and constant pain, with signs of peritoneal irritation. Atherosclerotic lesions were detected using abdominal computed tomography (CT) scans, through which other differential disease diagnoses were able to be excluded. Written informed consent was obtained from the patients. The study was approved by the ethics committee of Tianjin medical university (Tianjin, China).
Surgical procedure. The right common femoral artery was entered percutaneously using the Seldinger technique, and an 
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to flush out the emboli, the arteriotomy was closed and an angiogram was performed. If blood flow was not restored to the ischemic bowels after 15 min, a catheter (5F RH; Cordis Corporation) was inserted into the SMA for thrombolysis, with urokinase (4x10 5 IU; Biochem Pharmaceutical Corporation, Tianjin, China) administered over 20 min if necessary. Intra-arterial catheter-directed thrombolysis with urokinase (8x10 5 IU/24 h) was performed continuously for 48 h. In addition, doses of low molecular weight heparin calcium (86 IU/kg, twice a day) were administered to ensure adequate anticoagulation. The safety of the lytic treatment was evaluated every 12 h by testing the fibrinogen levels (range, 1.80-4.00 g/l). A second-look laparotomy was performed after 48 h to assess the health outcomes of the bowels, and anastomosis of the bowel segments was performed to restore bowel continuity. Acetylsalicylic acid or warfarin was subsequently administered long term to stabilize the prothrombin time-international normalized ratio (PT-INR) between 2-3 and fibrinogen between 2-4 g/L. The coagulation function of the patients requires monitoring weekly for at least 1 year and reduced to an appropriate frequency.
Clinical outcomes. Clinical success was defined as the recovery of the ischemic bowels and the resolution of clinical symptoms within the 30-day perioperative period. Clinical examinations, ultrasonography and/or CT-angiography of the SMA were performed to confirm the patency during the follow-up period. 
Results
Stenting. As shown in Fig. 2B , two patients required a single stent, which measured 6 mm in diameter and 40 mm in length (ev3 Endovascular, Inc.). These patients experienced a full recovery of the ischemic bowels following revascularization of the SMA during the laparotomy.
Intra-arterial catheter-directed thrombolysis. Four patients required intra-arterial catheter-directed thrombolysis following embolectomy and balloon angioplasty of the SMA (Fig. 1C and 1D ). However, one patient was found to have ~100 cm ischemic jejunum tissue following recanalization of the SMA during the first laparotomy. The other three patients exhibited massive bowel necrosis and underwent a necrotic bowel resection during the initial surgery, after which two patients were found to have necrotic small bowels from 80/70 cm proximal jejunum to 40/80 cm terminal ileum, respectively. Although the remaining jejunum was without evident necrosis, the viability of the tissue was poor. The remaining patient exhibited substantial necrosis of the right colon and massive small bowels, with only 90 cm ischemic proximal jejunum tissue. These four patients underwent intra-arterial catheter-directed thrombolysis for 48 h, and the ischemic bowels were shown to have recovered by the second-look surgery.
Clinical outcomes. Early clinical success was achieved in all the procedures. However, two patients developed acute renal failure postoperatively; one patient recovered after 10 days of dialysis, while the other individual succumbed to acute renal failure. In addition, two patients developed a wound infection. The three patients who underwent massive bowel resection did not develop short bowel syndrome.
Long-term follow-up outcomes. The patency of the SMA was maintained in the five surviving patients during the follow-up period. No patients have experienced recurrence of acute or chronic mesenteric ischemia since the surgical hybrid procedure (Table II) .
Discussion
Acute mesenteric ischemia secondary to a pre-existing SMA atherosclerotic disease is a surgical emergency associated with a poor prognosis. The condition requires prompt diagnosis and early revascularization in order to avoid massive bowel necrosis. Traditional approaches for achieving revascularization involve an antegrade aortomesenteric bypass or retrograde iliac artery to mesenteric artery bypass (3). However, the present study assessed the viability of a combined surgical and endovascular approach, using intraoperative retrograde balloon angioplasty or stenting during the laparotomy, followed by intra-arterial catheter-directed thrombolysis. The application of ROMS enabled the recanalization of the SMA to be more simple and quick, subsequently improving the mortality rate in patients with acute SMA thrombosis.
Milner et al (6) were the first to successfully perform the hybrid ROMS technique on an elderly patient with acute SMA thrombosis. Wyers et al (7) reported a 100% technical success rate using ROMS on six patients, with a mortality rate of 17%. The mortality rate of ROMS-treated patients was lower when compared with that of conventional surgical revascularization (80%) and a percutaneous stent (100%) for the treatment of arterial occlusive mesenteric ischemia in 13 patients. Stout et al (8) published a case report that included three patients with acute occlusive mesenteric ischemia who were treated with ROMS, which had a 100% technical success rate. In the present study, two patients were treated successfully with ROMS, with no technique-related complications or morbidity, although one patient succumbed to acute renal failure.
Previous studies have demonstrated the use of thrombolytic therapy in the treatment of acute mesenteric ischemia (9-11) ; however, to the best of our knowledge, no studies have applied intra-arterial catheter-directed thrombolysis following recanalization of the SMA. During the laparotomy of the three patients who underwent a massive bowel resection, only 20-30-cm sections of the proximal jejunums were observed to be viable, whereas an ischemic change was evident in the intestinal wall of the remaining proximal jejunum (50-60 cm). Successful treatment of the 50-60-cm section of the jejunum was necessary for the patients to survive surgery without developing short bowel syndrome. Treating these ischemic bowels was a critical health issue and the only viable treatment strategy was intra-arterial catheter-directed thrombolysis. Although the main trunk of the SMA was patent, a section of the distal vessel bed was occluded with thrombi. Constant intra-arterial catheter-directed thrombolysis may clear the microthrombus and reopen small branches of the SMA to improve the perfusion of the ischemic bowels. Although this thrombolytic therapy presents a risk of hemorrhage for patients simultaneously undergoing an exploratory laparotomy and bowel resection, intra-arterial catheter-directed thrombolysis was an alternative approach for the prevention of necrosis in the ischemic bowels. In the four patients that underwent this procedure in the present study, no bleeding was evident at the time of the thrombolytic therapy. Okamura et al have previously demonstrated that urokinase has no effect during surgery since the half-life in blood is only 16 min (11) . However, in the present study, adjusting the dose of urokinase according to the level of fibrinogen was attempted in order to avoid hemorrhage. Whether catheter-directed thrombolysis in the SMA hybrid surgery should be attempted depends mainly on the viability of the bowels once the SMA has been recanalized.
In conclusion, ROMS was demonstrated to be a viable alternative procedure for emergent SMA revascularization. In addition, intra-arterial catheter-directed thrombolysis following recanalization of the SMA may be an alternative treatment for preventing necrosis in the ischemic bowels of patients with acute mesenteric ischemia. In the future, larger clinical trials are required to investigate the clinical efficacy of the hybrid techniques in the treatment of arterial occlusive mesenteric ischemia.
